WallStreetZenWallStreetZen

NASDAQ: APLT
Applied Therapeutics Inc Stock Ownership - Who owns Applied Therapeutics?

Insider buying vs selling

Have Applied Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Leslie D. FuntleyderChief Financial Officer2024-03-1428,727$5.39
$154.84kSell
Shoshana ShendelmanPresident and CEO2024-03-14318,573$5.39
$1.72MSell
Riccardo PerfettiChief Medical Officer2024-03-14110,804$5.39
$597.23kSell
Adam HansardChief Commercial Officer2024-03-1448,871$5.39
$263.41kSell
Stacy J. KanterDirector2023-12-0130,000$2.18
$65.37kBuy
Riccardo PerfettiChief Medical Officer2023-11-301,583$1.97
$3.12kSell
Shoshana ShendelmanPresident and CEO2023-11-303,968$1.97
$7.82kSell
Adam HansardChief Commercial Officer2023-11-30965$1.97
$1.90kSell
Alexandria Real Estate Equities Inc10% Owner2023-11-03143,450$2.31
$331.37kSell
Alexandria Real Estate Equities Inc10% Owner2023-11-02103,808$2.32
$240.83kSell

1 of 2

APLT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APLT insiders and whales buy or sell their stock.

APLT Shareholders

What type of owners hold Applied Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Franklin Resources Inc6.63%7,017,912$36.14MInstitution
Vr Adviser LLC5.90%6,250,000$32.19MInstitution
Knoll Capital Management LLC5.17%5,474,687$28.19MInstitution
Propel Bio Management LLC5.08%5,374,982$27.68MInstitution
Shoshana Shendelman4.89%5,176,928$26.66MInsider
Vestal Point Capital LP3.92%4,155,000$21.40MInstitution
Perceptive Advisors LLC3.85%4,080,249$21.01MInstitution
Vanguard Group Inc3.05%3,230,481$16.64MInstitution
Alyeska Investment Group LP2.46%2,604,719$13.41MInstitution
Fmr LLC2.29%2,427,436$12.50MInstitution

1 of 3

APLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APLT57.95%8.47%Net SellingNet Selling
MESO0.14%0.00%
CELC52.40%15.32%Net SellingNet Selling
FATE61.86%38.14%Net BuyingNet Selling
ALT34.70%65.30%Net SellingNet Selling

Applied Therapeutics Stock Ownership FAQ

Who owns Applied Therapeutics?

Applied Therapeutics (NASDAQ: APLT) is owned by 57.95% institutional shareholders, 8.47% Applied Therapeutics insiders, and 33.58% retail investors. Shoshana Shendelman is the largest individual Applied Therapeutics shareholder, owning 5.18M shares representing 4.89% of the company. Shoshana Shendelman's Applied Therapeutics shares are currently valued at $25.00M.

If you're new to stock investing, here's how to buy Applied Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.